5
1
9780198832003
Oxford Textbook of Oncology / Edition 3 available in Hardcover, Paperback, eBook
Oxford Textbook of Oncology / Edition 3
by David J. Kerr, Daniel G. Haller, Cornelis J. H. van de Velde, Michael Baumann
David J. Kerr
- ISBN-10:
- 0198832001
- ISBN-13:
- 9780198832003
- Pub. Date:
- 10/21/2018
- Publisher:
- Oxford University Press
- ISBN-10:
- 0198832001
- ISBN-13:
- 9780198832003
- Pub. Date:
- 10/21/2018
- Publisher:
- Oxford University Press
Oxford Textbook of Oncology / Edition 3
by David J. Kerr, Daniel G. Haller, Cornelis J. H. van de Velde, Michael Baumann
David J. Kerr
$215.0
Buy New
$215.00
$215.00
-
SHIP THIS ITEM— Not Eligible for Free Shipping
215.0
In Stock
Overview
Now in paperback, the Oxford Textbook of Oncology reflects current best practice in the multidisciplinary management of cancer, written and edited by internationally recognised leaders in the field.
Structured in six sections, the book provides an accessible scientific basis to the key topics of oncology, examining how cancer cells grow and function, as well as discussing the aetiology of cancer, and the general principles governing modern approaches to oncology treatment. The book examines the challenges presented by the treatment of cancer on a larger scale within population groups, and the importance of recognising and supporting the needs of individual patients, both during and after treatment.
A series of disease-oriented, case-based chapters, ranging from acute leukaemia to colon cancer, highlight the various approaches available for managing the cancer patient, including the translational application of cancer science in order to personalise treatment. The advice imparted in these cases has relevance worldwide, and reflects a modern approach to cancer care.
The Oxford Textbook of Oncology provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests.
Structured in six sections, the book provides an accessible scientific basis to the key topics of oncology, examining how cancer cells grow and function, as well as discussing the aetiology of cancer, and the general principles governing modern approaches to oncology treatment. The book examines the challenges presented by the treatment of cancer on a larger scale within population groups, and the importance of recognising and supporting the needs of individual patients, both during and after treatment.
A series of disease-oriented, case-based chapters, ranging from acute leukaemia to colon cancer, highlight the various approaches available for managing the cancer patient, including the translational application of cancer science in order to personalise treatment. The advice imparted in these cases has relevance worldwide, and reflects a modern approach to cancer care.
The Oxford Textbook of Oncology provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests.
Product Details
| ISBN-13: | 9780198832003 |
|---|---|
| Publisher: | Oxford University Press |
| Publication date: | 10/21/2018 |
| Series: | Oxford Textbook |
| Edition description: | 3rd ed. |
| Pages: | 1036 |
| Product dimensions: | 10.91(w) x 8.67(h) x 1.88(d) |
About the Author
David J. Kerr, Professor of Cancer Medicine, Nuffield Division of Clinical Laboratory Sciences, Nuffield Department of Medicine, University of Oxford, Oxford, UK, Honorary Professor of Oncology, Xiamen and 2nd Military Universities, China, Honorary Professor, Seoul National University, Korea,Daniel G. Haller, Professor Emeritus, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA,Cornelis J. H. van de Velde, Professor of Surgery and Head, Department of Surgical Oncology, Leiden University Medical Center, The Netherlands,Michael Baumann, Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, Germany
Table of Contents
Section 1: Hallmarks of Cancer1. The hallmarks of cancer, Douglas Hanahan and Robert A. Weinberg2. Growth factors and uncontrolled proliferation, Shujuan Liu and Ahmed Ashour Ahmed3. Cell signalling pathways, Stefan Knapp4. Cell cycle control, Simon Carr and Nicholas La Thangue5. Cancer cell death, Amanda S. Coutts, Sandra Maniam, and Nicholas La Thangue6. Angiogenesis, Yull E. Arriaga and Arthur E. Frankel7. Invasion and metastases, Andrew P. Mazar, Andrey Ugolkov, Jack Henkin, Richard Ahn, and Thomas V. O'Halloran8. Genetic instability, Sir Walter Bodmer and Jenny Wilding9. DNA repair after oncological therapy, E. Dikomey, K. Borgmann, M. Kriegs, W. Mansour, C. Petersen, and T. Rieckmann10. Biology of cancer stem cells, Andreas Trumpp11. Biomarker identification and clinical validation, Richard D Kennedy, Manuel Salto-Tellez, D. Paul Harkin, and Patrick G Johnston12. Cancer, immunity, and inflammation, Campbell SD Roxburgh and Donald C McMillan13. Cancer and metabolism, Cameron Snell, Kevin C Gatter, Adrian L Harris, Francesco PezzellaSection 2: Etiology and Epidemiology of Cancer14. Smoking and cancer, Jonathan Samet15. Viruses, Chris Boshoff16. Chemical carcinogens, Paula A. Oliveira17. Radiation, Klaus Trott18. Body fatness, physical activity, diet, and other lifestyle factors, Ellen Kampman and Franzel van DuijnhovenSection 3: Principles of Oncology19. Practice points for surgical oncology, PG Boelens, CBM van den Broek, and CJH van de Velde20. Practice points for radiation oncology, Annekatrin Singer, Stephanie E. Combs, Jurgen Debus, and Michael Baumann21. Principles of chemotherapy, David Kerr, Daniel Haller, and Jaap Verweij22. Delivery of multidisciplinary cancer care, David N Church, Rachel S Midgley, and David J Kerr23. Principles of clinical pharmacology: Introduction to pharmacokinetics and pharmacodynamics, Michael Ong and Udai Banerji24. Design and analysis of clinical trials, Dan Sargeant and Qian Shi25. Medical ethics in oncology, Eric A. Singer26. Health economic assessment of cancer therapy, Jeffrey PeppercornSection 4: Population Health27. Cancer control: The role of national plans, Masoud Samiei28. Cancer prevention: Vaccination, Sarah Goltz and Julian Lob-Levyt29. Cancer prevention: Chemoprevention, Hans-Joerg Senn, Nadir Arber, and Dirk Schrijvers30. Population cancer screening, Andrew Evans, Simon Herrington, and Robert Steele31. Familial cancer syndromes and genetic counselling, Henry T. Lynch, Carrie L. Snyder, and Jane F. Lynch (deceased)Section 5: Support for the cancer patient32. Supportive palliative care, David Hui and Eduardo Bruera33. Quality of life, Neil Aaronson and Peter Fayers34. Cancer survivorship and rehabilitation, Rachel L. Yung and Ann H. PartridgeSection 6: Disease35. Cancer of the head and neck, Christine Chung, Andreas Dietz, Vincent Gregoire, Marco Guzzo, Marc Hamoir, Rene Leemans, Jean-Louis Lefebvre, Lisa Licitra, Adel El-Naggar, Brian O'Sullivan, Bing Tan, Vincent Vandecaveye, Vincent Vander Poorten, Jan Vermorken, and Michelle Williams36. Oesophageal cancer, Eric Van Cutsem, Christophe M. Deroose, Piet Dirix, Karin Haustermans, Tony Lerut, Philippe Nafteux, Hans Prenen, and Xavier Sagaert37. Gastric cancer, Hideaki Bando, Takahiro Kinoshita, Yasutoshi Kuboki, Atsushi Ohtsu, and Kohei Shitara38. Rectal cancer, Regina Beets-Tan, Bengt Glimelius, and Lars Pahlman39. Colon cancer, John Zalcberg, Stephen Fox, Alexander Heriot, Jon Knowles, Sam Ngan, Michael Michael, Kathryn Field, and Iris Nagtegaal40. Pancreatic cancer, J. Weitz, M.W. Buchler, Paul D Sykes, John P Neoptolemos, Eithne Costello, Christopher M Halloran, Frank Bergmann, Peter Schirmacher, Ulrich Bork, Stefan Fritz, Jens Werner, Thomas Brunner, Elizabeth Smyth, David Cunningham, Brian R. Untch, and Peter J. Allen41. Hepatobiliary cancer, Graeme J Poston, Nicholas Stern, Jonathan Evans, Priya Healey, Daniel Palmer, and Mohandas K. Mallath42. Peritoneal mesothelioma, H. Richard Alexander, Jr., Dario Baratti, Terence C. Chua, Marcello Deraco, Raffit Hassan, Marzia Pennati, Federica Perrone, Paul H. Sugarbaker, Anish Thomas, Keli Turner, Tristan D. Yan and Nadia Zaffaroni43. Cancer of the breast, Martine Piccart, Toral Gathani, Dimitrios Zardavas, Hatem A. Azim Jr., Christos Sotiriou, Giuseppe Viale, Emiel J T Rutgers, Mechthild Krause, Monica Arnedos, Suzette Delaloge, Fabrice Andre, and Felipe Ades44. Gynaecological cancers, Richard Potter, Shujuan Liu, Bolin Liu, Sebastien Gouy, Sigurd Lax, Eric Leblanc, Philippe Morice, Fabrice Narducci, Alexander Reinthaller, Maximilian P Schmid, Catherine Uzan, and Pauline Wimberger45. Genitourinary cancer, John Fitzpatrick, Asif Muneer , Jean de la Rosette, and Thomas Powles46. Lung cancer, Rafal Dziadziuszko, Michael Baumann, Tetsuya Mitsudomi, Keith M. Kerr, Solange Peters, and Stefan Zimmermann47. Neoplasms of the thymus, Rebecca Butof, Axel Denz, Gustavo Baretton, Jan Stohlmacher-Williams, and Michael Baumann48. Pleural mesothelioma, Andrea S. Wolf, Assunta De Rienzo, Raphael Bueno, Lucian R. Chirieac, Joseph Corson, Elizabeth H. Baldini, David Jackman, Ritu Gill, Walter Weder, Isabelle Opitz, Ann S. Adams, and David J. Sugarbaker49. Skin cancer: melanoma, John F Thompson, Richard A Scolyer, and Richard F Kefford50. Skin cancer: non-melonoma, Diona L. Damian, Richard A. Scolyer, Graham Stevens, Alexander Menzies, and John F. Thompson51. Acute leukemia, Adele K. Fielding, Charles G. Mullighan, Dieter Hoelzer, Eytan M. Stein, Ghada Zakout, Martin S. Tallman, Ross Levine, Yishai Ofran, Jacob M. Rowe, and Ross L. Levine52. Chronic leukemias, Hemant Malhotra, Lalit Kumar, Pankaj Malhotra, Devendra Hiwase, and Ravi Bhatia53. Myeloma, Charlotte Pawlyn, Faith Davies, and Gareth Morgan54. Lymphomas, Frank Kroschinsky, Friedrich Stolzel, Stefano A. Pileri, Bjoern Chapuy, Rainer Ordemann, Christian Gisselbrecht, Tim Illidge, David C. Hodgson, Mary K. Gospodarowicz, Christina Schutze, and Gerald Wulf55. Sarcomas of the soft tissue, Alessandro Gronchi, Angelo P. Dei Tos, and Paolo G. Casali56. Cancer of the central nervous system, Puneet Plaha, Allyson Parry, Pieter Pretorius, Michael Brada, Olaf Ansorge, and Claire Blessing57. Cancer of the eye and orbit, Daniel G. Ezra, Geoffrey E. Rose, Jacob Pe'er, Sarah Coupland, S. Seregard, G.P.M. Luyten, and Annette C. Moll58. Endocrine cancers, David Kerr, Andrew Weaver, Anthony P. Weetman, Oliver Gimm, Ashley Grossman, Petra Sulentic, Bertram Wiedenmann, Ulrich-Frank Pape, John Wass, Angela Rogers, and W de Herder59. Cancer of unknown primary site, Nicholas Pavlidis and George PentheroudakisIndexFrom the B&N Reads Blog
Page 1 of